Estimated reading time: 1 minutes
A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity.
About The Author
Discover more from Life is Pro-Mazing!
Subscribe to get the latest posts sent to your email.